|

GZR33 Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Gan and Lee Pharmaceuticals, USA1
  • Gan & Lee Pharmaceuticals.1

Indications

  • Diabetes2
  • Type 2 Diabetes (T2DM)1
  • Type 2 Diabetes1

Other2 trials

A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
Phase 2
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.